Physician profile
Tansy Ridings
NPI 1639466287
$7,245.03
in general payments reported to CMS, 2019-2025
35 companies · $1,002 in 2025
The $1,002 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,142 · 2022: $1,242 · 2023: $1,528 · 2024: $331 · 2025: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,860.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,975.96 | 2021-2023 | Bulkamid, Axonics |
| Astrazeneca Pharmaceuticals LP | $549.38 | 2021-2023 | Lynparza |
| Medtronic, INC. | $437.72 | 2022-2025 | Interstim |
| Sumitomo Pharma America, INC. | $434.44 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $431.87 | 2021-2024 | |
| Janssen Biotech, INC. | $376.14 | 2022-2025 | Carvykti, Rybrevant |
| Boston Scientific Corporation | $361.00 | 2021-2025 | Axonics |
| Astellas Pharma US INC | $349.11 | 2021-2025 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $319.90 | 2021-2023 | Xiaflex, Aveed |
| Pfizer INC. | $315.64 | 2021-2025 | |
| Myovant Sciences INC. | $250.01 | 2021-2022 | |
| Urogen Pharma, INC. | $210.63 | 2022-2025 | Jelmyto |
| Teleflex LLC | $147.70 | 2021 | |
| Olympus America INC. | $129.41 | 2023 | Itind System |
| Angiodynamics, INC. | $97.46 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $94.42 | 2022-2024 | Keytruda, Lynparza, Welireg |
| Kowa Pharmaceuticals America, INC. | $79.35 | 2022-2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $78.69 | 2025 | Adstiladrin |
| Blue Earth Diagnostics | $77.48 | 2021 | |
| Sun Pharmaceutical Industries INC. | $64.22 | 2022-2023 | Yonsa |
| Tolmar, INC. | $59.25 | 2023 | |
| Endo USA, INC. | $50.83 | 2025 | Xiaflex, Aveed |
| 180 Medical, INC. | $49.38 | 2021-2024 | |
| Myriad Genetic Laboratories, INC. | $44.20 | 2021-2025 | Prolaris |
| C. R. Bard, INC. & Subsidiaries | $43.52 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Urovant Sciences INC | $39.66 | 2022 | |
| Foundation Medicine, INC. | $36.44 | 2023 | Foundationone Liquid Cdx |
| Telix Pharmaceuticals | $34.15 | 2024 | Illuccix |
| Baxter Healthcare | $18.74 | 2023 | Tisseel |
| Antares Pharma, INC. | $17.93 | 2021 | |
| Abbvie INC. | $17.49 | 2025 | |
| Coloplast Corp | $17.06 | 2023 | Speedicath |
| Photocure INC | $16.22 | 2021 | |
| Acerus Pharmaceuticals Corporation | $13.32 | 2021 | |
| Travere Therapeutics, INC. | $6.31 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tansy Ridings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.